Blutgerinnung
NeuDie Studie ist in Englisch. Um Teil zu nehmen, müssen Sie der englischen oder holländischen Sprache mächtig sein.
- Rauchen
- Nicht-raucher
- Geschlecht
- Mann oder Frau
- Alter
- 50-79 jaar
?Note:
As a female you can only participate if you are not pregnant, not breast feeding and meet one of the following conditions from 4 weeks prior to the first administration in this trial:
As a male you can only participate if you meet one of the following conditions:
The trial consists of two parts: part A and part B. You can only participate (in one group of) one part in this trial.
Part A: This part consists of 1 period during which you will stay in the research facility in Groningen (location van Swietenlaan 6) for 6 days (5 nights). The follow-up visit will take place 5 to 7 days after your departure from the research facility.
Part A food effect: This group consists of 2 periods during which each period you will stay in the research facility in Groningen (location van Swietenlaan 6) for 6 days (5 nights). The follow-up visit will take place 5 to 7 days after your last departure from the research facility.
Part B: This part consists of 1 period during which you will stay in the research facility in Groningen (location van Swietenlaan 6) for 15 days (14 nights). The follow-up visit will take place 5 to 7 days after your departure from the research facility.
Note: You must be available for all dates to be able to participate in this clinical trial.
Group B2 | |
period of stay |
|
follow-up |
|
Travel expenses will be reimbursed based on the distance traveled (€ 0.21 net per kilometer) with a minimum of € 13 and a maximum of € 176.40 (840 kilometers) per round trip, regardless of the mode of transportation.